Staphylococcal Infections  >>  Cubicin (daptomycin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00463801 / 2006-004664-31: Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Terminated
4
52
Europe
Daptomycin
Novartis
Staphylococcal Skin Infections
11/07
 
DAPHEOR1006, NCT01419184: Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA

Completed
4
250
US
Daptomycin, Cubicin, Vancomycin
Cubist Pharmaceuticals LLC
Staphylococcal Skin Infections
09/12
10/12

Download Options